Attorney Ivan Wasserman talks on the legal implications of the reclassification of the probiotic genus lactobacillus into new genera.

Product formulators looking to support gut health can draw from ingredients consumers are already familiar with.

With cases of COVID-19 still on the rise across the globe, U.S. regulatory agencies respond to false product claims by hemp-derived product marketers, many surrounding immunity boosting.

Controversial and fly-by-night brands are caught up in latest FDA action against illegal disease claims for nutrient-infused products.

Determining whether a liquid energy product is a supplement or beverage guides its labeling, formulation and other compliance considerations.

CBD is everywhere, along with cure-all claims that can’t be fully backed by science. But the evidence does point to numerous beneficial effects, on many of the body’s key wellness systems.

Ingredient safety, product labeling, claims substantiation and adverse event reporting serve as four main pillars of supplement regulation.

More needs to be done in addition to issuing warning letters, one senator wrote, as targeted companies alter their promotions to comply.

As cases of COVID-19 spread across the globe, U.S. regulatory agencies respond to false product claims surrounding the outbreak with a wave of company warning letters.